Advertisement

Topics

Companies Related to "Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels" [Most Relevant Company Matches] RSS

00:11 EDT 24th October 2017 | BioPortfolio

Here are the most relevant search results for "Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels" found in our extensive corporate database of over 50,000 company records.

Showing "Effects Breastfeeding Maternal Plasma Ghrelin Peptide Tyrosine Tyrosine" Companies 1–25 of 729

Extremely Relevant

Tyrosine Pharma, Inc.

Tyrosine Pharma, Inc., is a New Mexico-based biotech start-up company and a New Mexico Angels Technology Showcase Company. Visit www.tyrosinepharma.com for additional information.


SGX Pharmaceuticals, Inc.

SGX Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of novel, targeted therapeutics directed at addressing unmet medical needs in oncology. Our drug development programs target the MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of Chronic Myelog...

SUGEN

SUGEN is a biopharmaceutical company focused on the discovery and development of small molecule drugs which target specific cellular signal transduction pathways. These signalling pathways are regulated by cell-surface receptors or intracellular signalling molecules known as tyrosine kinases ("TKs"), tyrosine phosphatases ("TPs") and serine-threonine kinases ("STKs"), thre...


Relevant

CEPTYR, Inc.

CEPTYR,® Inc., was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored domain in pharmaceutical development. We assembled the world’s leading experts in this field. Excellent progress has been made in identifying compelling PTP targets, and in novel chemistry for inhibitor drugs. Our first disease targeted is diabetes and obesity.

Peptide Resource Page

Welcome to the Peptide Resource Page (PRP). Founded in 2004, the PRP is designed to help researchers and educators navigate through the maze of peptide related websites. Search our pages to find peptide synthesis reagents, custom peptide suppliers, peptide property calculators, and much more. We also maintain an updated list of providers of peptide synthesizers and peptide sequencing services. The...

Exelixis Inc.

Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ® (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a highly...

VioQuest Pharmaceuticals

VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling precl...

Plasma Surgical

Founded in 2000, Plasma Surgical is a global company committed to advancing surgical technology that enhances the care and safety of patients during medical procedures. The company’s most revolutionary enhancement is the application of plasma surgery, where pure plasma is used to efficiently cut and coagulate tissue.

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those ...

Medela

Medela provides the most technologically advanced breast pumps and breastfeeding accessories to nursing mothers around the world. A long-time champion of breastfeeding, Medela is the only company to develop products based on research by the world's leading lactation experts. As a result, Medela's breast pumps are the number one choice of healthcare professionals and facilities worldwide.

Kolltan Pharmaceuticals, Inc.

Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need. Kolltan is developing a new generation of monoclonal antibody oncology therapeutics based on recent, seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the D...

ASI Technology

ASI Technology is a small business specializing in the development of advanced patented technologies in support of DOD and commercial organizations. This corporation owns two patented plasma technologies: 1. Plasma Sound Reduction 2. Plasma Decontamination & Sterilization From 1999 to 2003 we pioneered plasma antenna technology developing this new technology for DOD and commercial applications...

Velico Medical, Inc.

Velico Medical, Inc. is a clinical-stage company developing proprietary technologies intended to make blood transfusions safer, more effective and less costly. The Company’s leading product-candidate is a technology to enable the spray drying of plasma to improve its availability and eliminate costs related to frozen plasma, the current standard of care. ...

Ziarco

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting inflammatory and allergic diseases. The company’s product pipeline includes ZPL-3893787, an H4 receptor antagonist that has completed a Phase 1 multiple ascending dose study. A second clinical-stage, programme targets inflammatory disorders by inhibiting cyto...

ArQule, Inc.

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company’s targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule’s lead product, in Phase 2 clinical development, is ARQ 197, an in...

ADMA Biologics, Inc.

ADMA is a clinical stage biotechnology company which focuses its efforts on the development and commercialization of human plasma and plasma-derived therapeutics. ADMA’s mission is to develop and commercialize plasma-derived, human immune globulins targeted at niche patient populations with unmet medical needs. In addition, ADMA operates ADMA BioCente...

Breastfeeding.com, Inc.

Consortium for Plasma Science LLC

The Consortium for Plasma Science, LLC, was formed in January 1997 to support the development of a universal approach to eradicate pathogens in whole blood plasma. The Consortium is cofunded by Alpha Therapeutic Corporation, a subsidiary of Mitsubishi Pharma Corporation; Aventis Behring; Baxter Healthcare Corporation; and Bayer Corporation.The Member companies have agreed on a focused strategy to ...

PPTA Global

The Plasma Protein Therapeutics Association (PPTA) is the primary advocate for the world's leading source plasma collectors and producers of plasma-based and recombinant biological therapeutics. The medicines produced by PPTA members are used in treating life-threatening diseases and serious medical conditions including bleeding disorders, immune system deficiencies, alpha-1 antitrypsin deficienci...

PrIME Biologics Private Limited

PrIME Biologics is a Singapore-based biotech company that has developed a disposable therapeutic plasma manufacturing process based on PrIME technology—Preparative Isolation by Membrane Electrophoresis. PrIME is pioneering this technique in its plasma manufacturing plant in Singapore to address the US$1 billion Asian plasma derivative market.

PeptiDream Inc.

PeptiDream Inc. is a public (Tokyo Stock Exchange Mothers 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System (PDPS), a state-of-the-art highly versatile peptide generation and selection platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high effici...

Capralogics Inc

In our state of art collection and processing facility Capralogics offers large scale production of liters of high quality goat plasma, defibrinated plasma, and serum

Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's internally developed drug pipeline utilizes proprietary approaches to discover potent rigid conformers from flexible peptide starting points. Palatin's strategy is to develop p...

CSL Behring

CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.

Tranzyme Pharma

Tranzyme Pharma is a clinical-stage drug development company that discovers and develops novel small molecule macrocyclic drugs for both acute care (hospital-based) and chronic indications with significant unmet medical needs. The Company's pipeline is derived from its proprietary drug discovery (chemistry) technology, MATCH™, and targets products for...


More From BioPortfolio on "Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels"

Quick Search
Advertisement
 

Corporate Database Quicklinks